Heidi Johanna Rayala, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostate | 1 | 2023 | 1781 | 0.490 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 11221 | 0.250 |
Why?
|
| Medicare | 1 | 2023 | 6881 | 0.240 |
Why?
|
| Language | 2 | 2023 | 1558 | 0.220 |
Why?
|
| Nitrous Oxide | 1 | 2023 | 166 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6971 | 0.210 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2003 | 164 | 0.200 |
Why?
|
| Haiti | 1 | 2023 | 553 | 0.190 |
Why?
|
| Prostatectomy | 1 | 2009 | 1841 | 0.190 |
Why?
|
| Lidocaine | 1 | 2023 | 545 | 0.180 |
Why?
|
| Cytoplasm | 1 | 2003 | 1502 | 0.160 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 3236 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 2023 | 1004 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21162 | 0.130 |
Why?
|
| Kidney Pelvis | 1 | 1997 | 195 | 0.130 |
Why?
|
| Ureteral Obstruction | 1 | 1997 | 297 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2003 | 2886 | 0.120 |
Why?
|
| Oxygen | 1 | 2023 | 4273 | 0.100 |
Why?
|
| Biopsy | 1 | 2023 | 6808 | 0.100 |
Why?
|
| Laparoscopy | 3 | 1997 | 2056 | 0.090 |
Why?
|
| Renal Veins | 1 | 2010 | 103 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4936 | 0.090 |
Why?
|
| Ureter | 3 | 1997 | 370 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 2257 | 0.090 |
Why?
|
| Muscle Neoplasms | 1 | 2010 | 130 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2023 | 12456 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 167 | 0.080 |
Why?
|
| Pain | 1 | 2023 | 5103 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3276 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 3413 | 0.070 |
Why?
|
| Electrosurgery | 2 | 1997 | 53 | 0.070 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2003 | 73 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2022 | 92 | 0.050 |
Why?
|
| Swine, Miniature | 4 | 1997 | 965 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 461 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2009 | 1509 | 0.050 |
Why?
|
| Brachytherapy | 1 | 2009 | 1226 | 0.050 |
Why?
|
| Urinary Bladder | 2 | 1997 | 1162 | 0.040 |
Why?
|
| Aged | 3 | 2023 | 171562 | 0.040 |
Why?
|
| Swine | 7 | 1997 | 5994 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2022 | 383 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2022 | 3633 | 0.040 |
Why?
|
| Oocytes | 1 | 2004 | 1171 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2750 | 0.040 |
Why?
|
| Male | 5 | 2023 | 364902 | 0.040 |
Why?
|
| Biological Transport | 1 | 2003 | 2085 | 0.040 |
Why?
|
| Urography | 2 | 1997 | 316 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 54920 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 768393 | 0.040 |
Why?
|
| Water | 1 | 2004 | 1418 | 0.040 |
Why?
|
| Mineral Oil | 1 | 1997 | 22 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2003 | 3088 | 0.040 |
Why?
|
| Emollients | 1 | 1997 | 42 | 0.040 |
Why?
|
| Anatomy, Comparative | 1 | 1996 | 4 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 998 | 0.040 |
Why?
|
| Kidney | 3 | 1997 | 7064 | 0.040 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1997 | 43 | 0.030 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1997 | 87 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3779 | 0.030 |
Why?
|
| Tissue Adhesives | 1 | 1997 | 179 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 3200 | 0.030 |
Why?
|
| United States | 1 | 2023 | 73150 | 0.030 |
Why?
|
| Sex Determination Analysis | 1 | 1995 | 46 | 0.030 |
Why?
|
| Renal Artery | 1 | 1997 | 353 | 0.030 |
Why?
|
| Ultrasonic Therapy | 1 | 1997 | 217 | 0.030 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 1995 | 35 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 1997 | 681 | 0.030 |
Why?
|
| Genes, Plant | 1 | 1995 | 129 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 1995 | 170 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 1997 | 2862 | 0.030 |
Why?
|
| Electrodes | 1 | 1997 | 617 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 4303 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8051 | 0.030 |
Why?
|
| Reference Values | 2 | 1997 | 4941 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 17626 | 0.030 |
Why?
|
| Lasers | 1 | 1997 | 952 | 0.030 |
Why?
|
| Plant Proteins | 1 | 1995 | 376 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1997 | 777 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13423 | 0.020 |
Why?
|
| Nephrectomy | 1 | 1997 | 949 | 0.020 |
Why?
|
| Protein Binding | 1 | 2003 | 9343 | 0.020 |
Why?
|
| Middle Aged | 3 | 2022 | 223491 | 0.020 |
Why?
|
| Female | 8 | 2023 | 397089 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12805 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1997 | 6241 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15872 | 0.020 |
Why?
|
| Sodium Azide | 1 | 2004 | 24 | 0.020 |
Why?
|
| Urothelium | 2 | 1997 | 276 | 0.010 |
Why?
|
| Nocodazole | 1 | 2004 | 95 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 36849 | 0.010 |
Why?
|
| Random Allocation | 2 | 1997 | 2397 | 0.010 |
Why?
|
| Diffusion | 1 | 2004 | 818 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 710 | 0.010 |
Why?
|
| Animals | 9 | 2004 | 169337 | 0.010 |
Why?
|
| Tubulin | 1 | 2004 | 695 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1997 | 18362 | 0.010 |
Why?
|
| Equipment Design | 2 | 1997 | 3529 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2002 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1996 | 50 | 0.010 |
Why?
|
| Rats, Nude | 1 | 1996 | 106 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 5037 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 39407 | 0.010 |
Why?
|
| Agglutinins | 1 | 1995 | 28 | 0.010 |
Why?
|
| Agglutination | 1 | 1995 | 42 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1995 | 94 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1995 | 109 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 6350 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1995 | 342 | 0.010 |
Why?
|
| Sheep | 1 | 1996 | 1451 | 0.010 |
Why?
|
| Pressure | 1 | 1997 | 1172 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1997 | 1502 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1997 | 1376 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 643 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 930 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1431 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 3846 | 0.010 |
Why?
|
| Organ Size | 1 | 1997 | 2268 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1915 | 0.010 |
Why?
|
| Germ Cells | 1 | 1995 | 643 | 0.010 |
Why?
|
| Rabbits | 1 | 1996 | 4781 | 0.010 |
Why?
|
| Fibrosis | 1 | 1997 | 2077 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 30022 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 223640 | 0.000 |
Why?
|
| Inflammation | 2 | 1997 | 10863 | 0.000 |
Why?
|
| Endoscopy | 1 | 1997 | 1857 | 0.000 |
Why?
|
| Models, Genetic | 1 | 1995 | 3442 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12422 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 81801 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1997 | 8541 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 23835 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 9063 | 0.000 |
Why?
|
| Phenotype | 1 | 1995 | 16721 | 0.000 |
Why?
|